Cargando…

Role of resistin as a marker of inflammation in systemic lupus erythematosus

INTRODUCTION: Resistin is a cystein-rich secretory adipokine. It is proposed to have proinflammatory properties in humans. The aim of this study was to determine associations between serum levels of resistin and markers of inflammation and bone mineral density (BMD) in female patients with systemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Almehed, Katarina, d'Elia, Helena Forsblad, Bokarewa, Maria, Carlsten, Hans
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374439/
https://www.ncbi.nlm.nih.gov/pubmed/18234104
http://dx.doi.org/10.1186/ar2366
_version_ 1782154453939388416
author Almehed, Katarina
d'Elia, Helena Forsblad
Bokarewa, Maria
Carlsten, Hans
author_facet Almehed, Katarina
d'Elia, Helena Forsblad
Bokarewa, Maria
Carlsten, Hans
author_sort Almehed, Katarina
collection PubMed
description INTRODUCTION: Resistin is a cystein-rich secretory adipokine. It is proposed to have proinflammatory properties in humans. The aim of this study was to determine associations between serum levels of resistin and markers of inflammation and bone mineral density (BMD) in female patients with systemic lupus erythematosus (SLE). METHODS: One hundred sixty-three female patients with SLE (20 to 82 years old) were examined in a cross-sectional study. Venous blood samples were analyzed for resistin, erythrocyte sedimentation rate (ESR), C-reactive protein, creatinine, fasting lipids, complements, tumor necrosis factor-alpha, interleukin (IL)-1β, IL-6, sIL-6R (soluble IL-6 receptor), ICTP (C-terminal telopeptide of type I collagen), and PINP (N-terminal propeptide of type I procollagen). Simple and multiple regression analyses as well as logistic regression analyses were performed. Resistin in serum was compared with 42 healthy female controls with respect to age. RESULTS: Serum resistin levels in controls were similar to those of patients with SLE. Markers of inflammation and current dose of glucocorticosteroids correlated positively to resistin in serum. Markers of renal function, number of prevalent vertebral fractures, and BMD were also significantly associated with resistin. In a multiple regression model, ESR, creatinine, C3, current glucocorticosteroid dose, high-density lipoprotein, and BMD radius remained significantly associated with resistin. In logistic regression analyses with resistin as the independent variable, a significant association was found with ESR (normal or elevated) but not with S-creatinine or z score for hip and radius total. CONCLUSION: Although resistin measurements did not differ between patients and controls, resistin was clearly associated with general inflammation, renal disease, treatment with glucocorticosteroids, and bone loss. We hypothesize that resistin has proinflammatory and disease-promoting properties in SLE. Further studies are needed to elucidate the mechanism behind these associations.
format Text
id pubmed-2374439
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-23744392008-05-09 Role of resistin as a marker of inflammation in systemic lupus erythematosus Almehed, Katarina d'Elia, Helena Forsblad Bokarewa, Maria Carlsten, Hans Arthritis Res Ther Research Article INTRODUCTION: Resistin is a cystein-rich secretory adipokine. It is proposed to have proinflammatory properties in humans. The aim of this study was to determine associations between serum levels of resistin and markers of inflammation and bone mineral density (BMD) in female patients with systemic lupus erythematosus (SLE). METHODS: One hundred sixty-three female patients with SLE (20 to 82 years old) were examined in a cross-sectional study. Venous blood samples were analyzed for resistin, erythrocyte sedimentation rate (ESR), C-reactive protein, creatinine, fasting lipids, complements, tumor necrosis factor-alpha, interleukin (IL)-1β, IL-6, sIL-6R (soluble IL-6 receptor), ICTP (C-terminal telopeptide of type I collagen), and PINP (N-terminal propeptide of type I procollagen). Simple and multiple regression analyses as well as logistic regression analyses were performed. Resistin in serum was compared with 42 healthy female controls with respect to age. RESULTS: Serum resistin levels in controls were similar to those of patients with SLE. Markers of inflammation and current dose of glucocorticosteroids correlated positively to resistin in serum. Markers of renal function, number of prevalent vertebral fractures, and BMD were also significantly associated with resistin. In a multiple regression model, ESR, creatinine, C3, current glucocorticosteroid dose, high-density lipoprotein, and BMD radius remained significantly associated with resistin. In logistic regression analyses with resistin as the independent variable, a significant association was found with ESR (normal or elevated) but not with S-creatinine or z score for hip and radius total. CONCLUSION: Although resistin measurements did not differ between patients and controls, resistin was clearly associated with general inflammation, renal disease, treatment with glucocorticosteroids, and bone loss. We hypothesize that resistin has proinflammatory and disease-promoting properties in SLE. Further studies are needed to elucidate the mechanism behind these associations. BioMed Central 2008 2008-01-30 /pmc/articles/PMC2374439/ /pubmed/18234104 http://dx.doi.org/10.1186/ar2366 Text en Copyright © 2008 Almehed et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Almehed, Katarina
d'Elia, Helena Forsblad
Bokarewa, Maria
Carlsten, Hans
Role of resistin as a marker of inflammation in systemic lupus erythematosus
title Role of resistin as a marker of inflammation in systemic lupus erythematosus
title_full Role of resistin as a marker of inflammation in systemic lupus erythematosus
title_fullStr Role of resistin as a marker of inflammation in systemic lupus erythematosus
title_full_unstemmed Role of resistin as a marker of inflammation in systemic lupus erythematosus
title_short Role of resistin as a marker of inflammation in systemic lupus erythematosus
title_sort role of resistin as a marker of inflammation in systemic lupus erythematosus
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374439/
https://www.ncbi.nlm.nih.gov/pubmed/18234104
http://dx.doi.org/10.1186/ar2366
work_keys_str_mv AT almehedkatarina roleofresistinasamarkerofinflammationinsystemiclupuserythematosus
AT deliahelenaforsblad roleofresistinasamarkerofinflammationinsystemiclupuserythematosus
AT bokarewamaria roleofresistinasamarkerofinflammationinsystemiclupuserythematosus
AT carlstenhans roleofresistinasamarkerofinflammationinsystemiclupuserythematosus